Current Colorectal Cancer Reports
Published by Springer Nature
ISSN : 1556-3790 eISSN : 1556-3804
Abbreviation : Curr. Colorectal Cancer Rep.
Aims & Scope
This journal aims to review the most important, recently published clinical findings related to the diagnosis, treatment, management, and prevention of colorectal cancer.
By providing clear, insightful, balanced contributions by international experts, the journal intends to serve all those involved in the care of those with the disease.
We accomplish this aim by appointing international authorities to serve as Section Editors in key subject areas, such as current and emerging therapeutic approaches and the molecular basis of disease.
Section Editors, in turn, select topics for which leading experts contribute comprehensive review articles that emphasize new developments and recently published papers of major importance, highlighted by annotated reference lists.
An international Editorial Board reviews the annual table of contents, suggests articles of special interest to their country/region, and ensures that topics are current and include emerging research.
Commentaries from well-known figures in the field are also provided.
View Aims & ScopeAbstracting & Indexing
Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.
Subjects & Keywords
Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine, designed to support cutting-edge academic discovery.
Most Cited Articles
The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.
-
Neoadjuvant Rectal (NAR) Score: a New Surrogate Endpoint in Rectal Cancer Clinical Trials
Citation: 125
Authors: Thomas J., Carmen J., Greg
-
Lifestyle, Diet, and Colorectal Cancer Risk According to (Epi)genetic Instability: Current Evidence and Future Directions of Molecular Pathological Epidemiology
Citation: 94
Authors: Laura A. E., Colinda C. J. M., Piet A., Manon, Matty P.
-
The IDEA (International Duration Evaluation of Adjuvant Chemotherapy) Collaboration: Prospective Combined Analysis of Phase III Trials Investigating Duration of Adjuvant Therapy with the FOLFOX (FOLFOX4 or Modified FOLFOX6) or XELOX (3 versus 6Â months) Regimen for Patients with Stage III Colon Cancer: Trial Design and Current Status
Citation: 88
Authors: Thierry, Timothy, Roberto, Jeffrey A., Ioannis, Takayuki, James, Alberto, Julien, Anthony F., Atsushi, Axel, Daniel J.
-
Dietary Patterns and Colorectal Cancer Risk: a Review of 17 Years of Evidence (2000–2016)
Citation: 86
Authors: Fred K., Lisa S., Teresa T.